PRESENTATIONNATION

PRESENTATIONNATION

Browse a growing database of presentations shared by companies worldwide.

Browse

Browse All
All Companies
Presentations
Infographics
Reports
Brochures

Company

Blog
About
Contact

Legal

Privacy Policy
Terms of Service

© 2026 Presentation Nation. All rights reserved.
Built in San Diego by Twenty6 Red, Inc.

HomepageAllogene TherapeuticsALPHA2-Study

ALPHA2-Study

Allogene Therapeutics

Browse presentations, reports, and documents from Allogene Therapeutics.

Filter options

All (30)●
brochure (1)○
presentation (28)○
report (1)○

Get the best presentations in your inbox

Join professionals who get a weekly curated collection of top business presentations, investor decks, and industry reports — free.

No spam. Unsubscribe anytime.

Loading viewer...

report

Format: PDF report

Share:

The ALPHA2 Study presents updated results on the safety and efficacy of ALLO-501A, an allogeneic CAR T cell therapy for LBCL patients.

Browse all reports →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Allogene Therapeutics

12701_AllogeneESGReport2023_6

brochure

22-007-ASH-2022-UNIVERSAL-Presentation-Slides-V5-DB

presentation

Similar reports from other companies

FFB-Annual-Report-2023-Electronic

report

First Federal Bancorp

Crane-Co-PSE-Report-2020

report

Crane Company

wellness2024

270c7345-df2b-457b-a086-55896a122a99

presentation

A_Fratricide_Resistant_Allogeneic_CAR_T_Targeting_CD70

presentation

Allogene Therapeutics__2023__181_93181

presentation

Allogene Therapeutics_August_2022_763_86763

presentation

report

Fox Valley Tool & Die

AAON Inc._2013_Annual_Report

report

AAON Inc

bp-energy-outlook-2023

report

BP

Snap_July_2019_479_47479

report

Snap

ALPHA2-Study - Allogene Therapeutics | Presentation Nation